Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

L-asparaginase is an integral component of therapy for acute lymphoblastic leukemia. However, asparaginase-related complications, including the development of hypersensitivity reactions, can limit its use in individual patients. Of considerable concern in the setting of clinical allergy is the devel...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	Inge M. van der Sluis, Lynda M. Vrooman, Rob Pieters, Andre Baruchel, Gabriele Escherich, Nicholas Goulden, Veerle Mondelaers, Jose Sanchez de Toledo, Carmelo Rizzari, Lewis B. Silverman, James A. Whitlock
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2016-03-01
Online Access:	https://haematologica.org/article/view/7646